( NYSE:VRX,Toronto:VRX )

News from valeant pharmaceuticals international, inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Jul 23, 2015, 06:00 ET Valeant Pharmaceuticals Reports Second Quarter 2015 Financial Results

2015 Second Quarter Results - Total Revenue $2.7 billion; an increase of 34% over the prior year - Excluding negative impact of...


Jul 17, 2015, 08:00 ET Valeant Pharmaceuticals Agrees To Acquire Amoun Pharmaceutical

 Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) today announced that it has entered into a definitive agreement under...


Jun 24, 2015, 08:00 ET Valeant Pharmaceuticals To Announce 2015 Second Quarter Results On July 23, 2015

 Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that it will host a conference call and a live Internet...


Jun 23, 2015, 09:15 ET Valeant and Progenics Announce the Submission of U.S. New Drug Application for Oral RELISTOR®

 Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) and Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX) today...


Jun 11, 2015, 09:00 ET Valeant Pharmaceuticals To Appoint Robert L. Rosiello As Chief Financial Officer

 Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) announced today that Robert L. Rosiello was appointed as Executive Vice...


May 27, 2015, 17:59 ET Salix Announces FDA Approval of Xifaxan® 550 mg for the Treatment of IBS-D (Irritable Bowel Syndrome with Diarrhea)

Xifaxan® 550 mg is the first-and-only nonsystemic antibiotic approved for the treatment of IBS-D in adults  Valeant Pharmaceuticals...


May 19, 2015, 17:00 ET Valeant Pharmaceuticals Announces 2015 Annual Meeting Results

 Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced the election of eleven directors nominated at its 2015...


May 12, 2015, 16:05 ET Valeant Pharmaceuticals To Webcast 2015 Annual Meeting Of Shareholders

Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that it will conduct a live webcast of the company's annual...


Apr 29, 2015, 06:00 ET Valeant Announces CFO Succession Plan And Additional Executive Appointment

Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that Howard B. Schiller has advised the Company of his decision...


Apr 29, 2015, 06:00 ET Valeant Pharmaceuticals Reports First Quarter 2015 Financial Results

2015 First Quarter Results - Total Revenue $2.2 billion; an increase of 16% over the prior year despite negative foreign exchange impact of...


Apr 24, 2015, 09:14 ET RELISTOR® Receives Positive CHMP Opinion in the EU for the Treatment of Opioid-Induced Constipation in Adults with Chronic Non-Cancer Pain

Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) and Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX) today announced...


Apr 09, 2015, 08:00 ET Valeant Pharmaceuticals To Announce 2015 First Quarter Results On April 29, 2015

Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that it will host a conference call and a live Internet webcast...


Apr 01, 2015, 17:00 ET Salix Provides Notice of Fundamental Changes, Make-Whole Fundamental Changes and Merger Event Relating to Its 2.75% Convertible Senior Notes Due 2015

 Salix Pharmaceuticals, Ltd. (the "Company" or "Salix"), a wholly owned subsidiary of Valeant Pharmaceuticals International, Inc. (NYSE: VRX)...


Apr 01, 2015, 17:00 ET Salix Provides Notice of Fundamental Changes, Make-Whole Fundamental Changes and Merger Event Relating to Its 1.5% Convertible Senior Notes Due 2019

Salix Pharmaceuticals, Ltd. (the "Company" or "Salix"), a wholly owned subsidiary of Valeant Pharmaceuticals International, Inc. (NYSE: VRX)...


Apr 01, 2015, 09:05 ET Redemption of All of Salix's Outstanding 6.00% Senior Notes due 2021

 Salix Pharmaceuticals, Ltd. ("Salix"), a wholly owned subsidiary of Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX:VRX), today...


Apr 01, 2015, 09:00 ET Valeant Pharmaceuticals International, Inc. Completes Acquisition Of Salix Pharmaceuticals

Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) today announced it has completed the previously announced acquisition of Salix...


Apr 01, 2015, 06:00 ET Valeant Pharmaceuticals International, Inc. Completes Tender Offer For Salix Pharmaceuticals, Ltd.

Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) ("Valeant") today announced the expiration of the tender offer (the "Offer")...


Mar 27, 2015, 10:09 ET Valeant Pharmaceuticals Closes Offering Of $1.45 Billion Of Common Shares

 Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) announced today the closing of its previously announced registered offering...


Mar 17, 2015, 09:00 ET Valeant Pharmaceuticals Prices Offering Of $1.45 Billion Of Common Shares

Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) has priced its previously announced registered offering of common shares in the...


Mar 16, 2015, 16:01 ET Valeant Pharmaceuticals Announces Offering Of $1.45 Billion Of Common Shares

 Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) announced today that it has filed with the U.S. Securities and Exchange...